4//SEC Filing
Brennan Nora 4
Accession 0001192482-19-000425
CIK 0001561921other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 8:52 PM ET
Size
7.2 KB
Accession
0001192482-19-000425
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Brennan Nora
Chief Financial Officer
Transactions
- Conversion
Common Stock
2019-11-13+3,491→ 3,668 total - Conversion
Series B Preferred Stock
2019-11-13−86,200→ 0 total→ Common Stock (3,491 underlying)
Footnotes (3)
- [F1]Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
- [F2]Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.
- [F3]Reflects 177 shares of common stock received by the reporting person as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
Documents
Issuer
TELA Bio, Inc.
CIK 0001561921
Entity typeother
Related Parties
1- filerCIK 0001790215
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 8:52 PM ET
- Size
- 7.2 KB